Posted by Michael Wonder on 23 Jan 2023
EMA publishes agenda for 23-26 January 2023 CHMP meeting
23 January 2023 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Dabigatran etexilate
- Dapagliflozin
- Sitagliptin with metformin hydrochloride
- Palovarotene
- Deucravacitinib
- Tolvaptan
